Company Performance Metrics
Soqut Imaging develops MRI-based quantitative imaging software for non-invasive assessment of metabolic liver diseases. The company focuses on tools that help clinicians diagnose and monitor conditions such as MAFLD and MASH using quantitative MRI data. Its software processes MRI scans to characterize liver tissue composition, including
three-dimensional fat and iron content and fibrosis presence and severity. Soqut Imaging targets university hospitals, specialist hepatology centers, pharmaceutical companies, and contract research organizations. Its technology supports patient diagnosis, treatment decision-making, and longitudinal monitoring, and is also used to evaluate drug effects in clinical trials. The company positions its products as integrated medical imaging solutions that fit into existing MRI workflows and reporting practices.